![](../../files/images/goods/M31600.png)
Crenulatin
CAS No. 63026-02-8
Crenulatin ( —— )
产品货号. M31600 CAS No. 63026-02-8
Crenulatin has dual- direction effects on apoptosis of cerebral microvascular endothelial cells, inhibitive effect in 25 mg/L and stimulative effect in 100 mg/L group, respectively; the mechanism is related to the alterations of Fas/Bcl-2 expression and caspase-3 activity.
纯度: >98% (HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2020 | 有现货 |
![]() ![]() |
50MG | 获取报价 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Crenulatin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Crenulatin has dual- direction effects on apoptosis of cerebral microvascular endothelial cells, inhibitive effect in 25 mg/L and stimulative effect in 100 mg/L group, respectively; the mechanism is related to the alterations of Fas/Bcl-2 expression and caspase-3 activity.
-
产品描述Crenulatin has dual- direction effects on apoptosis of cerebral microvascular endothelial cells, inhibitive effect in 25 mg/L and stimulative effect in 100 mg/L group, respectively; the mechanism is related to the alterations of Fas/Bcl-2 expression and caspase-3 activity.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number63026-02-8
-
分子量248.27
-
分子式C11H20O6
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/new12.jpg)
![](/themes/theme/en/images/gift.jpg)
![](/themes/theme/en/images/ct2.png)
关联产品
-
Atractylenolide I
Atractylenolide-I 通过抑制 TNF-α 和 IL-6 的产生而具有抗炎作用;通过减少促炎细胞因子和 LPS 改善脓毒症综合征、肝肾功能。
-
TCV-309 chloride
一种高效、选择性的血小板激活因子(PAF)拮抗剂;抑制 PAF 诱导的兔和人血小板聚集,IC50 分别为 33 nM 和 55 nM;有效保护小鼠免受 PAF 和过敏性休克引起的死亡,ED50 分别为 2.1 和 2.6 ug/kg (iv);还可逆转大鼠中 PAF 引起的低血压和内毒素引起的低血压。
-
AT-406 HCl
AT-406,一种口服活性的多重凋亡蛋白抑制剂 (IAP) 拮抗剂。